v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   132,992      
Beginning balance at Dec. 31, 2023 $ 979,488 $ 3 $ 1,815,245 $ (1,008) $ (834,752)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   119      
Exercise of vested stock options 291   291    
Vesting of restricted stock units (in shares)   2,852      
Shares issued under bonus program (in shares)   1,889      
Shares issued under bonus program $ 26,849   26,849    
Shares issued under employee stock purchase program (in shares) 500 544      
Shares issued under employee stock purchase program $ 4,053   4,053    
Stock-based compensation 56,936   56,936    
Net loss (87,156)       (87,156)
Other comprehensive (loss) income 726     726  
Ending balance (in shares) at Jun. 30, 2024   138,396      
Ending balance at Jun. 30, 2024 981,187 $ 3 1,903,374 (282) (921,908)
Beginning balance (in shares) at Mar. 31, 2024   136,484      
Beginning balance at Mar. 31, 2024 991,806 $ 3 1,870,503 (521) (878,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   48      
Exercise of vested stock options $ 180   180    
Vesting of restricted stock units (in shares)   1,320      
Shares issued under employee stock purchase program (in shares) 500 544      
Shares issued under employee stock purchase program $ 4,053   4,053    
Stock-based compensation 28,638   28,638    
Net loss (43,729)       (43,729)
Other comprehensive (loss) income 239     239  
Ending balance (in shares) at Jun. 30, 2024   138,396      
Ending balance at Jun. 30, 2024 981,187 $ 3 1,903,374 (282) (921,908)
Beginning balance (in shares) at Dec. 31, 2024   142,086      
Beginning balance at Dec. 31, 2024 $ 965,250 $ 3 1,958,157 (100) (992,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares) 317 317      
Exercise of vested stock options $ 687   687    
Vesting of restricted stock units (in shares)   3,304      
Shares issued under bonus program (in shares)   951      
Shares issued under bonus program $ 6,898   6,898    
Shares issued under employee stock purchase program (in shares) 500 514      
Shares issued under employee stock purchase program $ 3,325   3,325    
Stock-based compensation 43,245   43,245    
Net loss (76,689)       (76,689)
Other comprehensive (loss) income (69)     (69)  
Ending balance (in shares) at Jun. 30, 2025   147,172      
Ending balance at Jun. 30, 2025 942,647 $ 3 2,012,312 (169) (1,069,499)
Beginning balance (in shares) at Mar. 31, 2025   144,686      
Beginning balance at Mar. 31, 2025 957,023 $ 3 1,989,108 (130) (1,031,958)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   149      
Exercise of vested stock options $ 279   279    
Vesting of restricted stock units (in shares)   1,823      
Shares issued under employee stock purchase program (in shares) 500 514      
Shares issued under employee stock purchase program $ 3,325   3,325    
Stock-based compensation 19,600   19,600    
Net loss (37,541)       (37,541)
Other comprehensive (loss) income (39)     (39)  
Ending balance (in shares) at Jun. 30, 2025   147,172      
Ending balance at Jun. 30, 2025 $ 942,647 $ 3 $ 2,012,312 $ (169) $ (1,069,499)